ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Sigilon Therapeutics Inc

Sigilon Therapeutics Inc (SGTX)

22.47
0.00
(0.00%)
Cerrado 26 Noviembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
22.47
Postura de Compra
21.80
Postura de Venta
23.01
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
22.47
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

SGTX Últimas noticias

Lilly Completes Acquisition of Sigilon Therapeutics

Lilly Completes Acquisition of Sigilon Therapeutics PR Newswire INDIANAPOLIS, Aug. 14, 2023 INDIANAPOLIS, Aug. 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PSTXPoseida Therapeutics Inc
US$ 9.38
(227.97%)
29.42M
IMGCIMG Inc
US$ 1.615
(156.35%)
114.46M
IDAIT Stamp Inc
US$ 0.364
(102.22%)
549.04M
PGHLPrimega Group Holdings Ltd
US$ 20.95
(98.77%)
2.77M
TOYOTOYO Company Ltd
US$ 5.41
(86.55%)
48.64M
ALECAlector Inc
US$ 2.575
(-34.97%)
8.13M
ABVEAbove Food Ingredients Inc
US$ 0.5338
(-34.42%)
1.66M
LGCLLucas GC Ltd
US$ 0.7511
(-33.53%)
2.48M
ADDColor Star Technology Company Ltd
US$ 4.19
(-31.87%)
205.78k
LESLLeslies Inc
US$ 2.445
(-30.34%)
24.55M
IDAIT Stamp Inc
US$ 0.364
(102.22%)
549.04M
ELABElevai Labs Inc
US$ 0.01255
(-21.07%)
323.24M
NVDANVIDIA Corporation
US$ 136.92
(0.66%)
186M
RGTIRigetti Computing Inc
US$ 2.195
(-20.18%)
124.14M
IMGCIMG Inc
US$ 1.615
(156.35%)
114.46M

SGTX Discussion

Ver más
Invest-in-America Invest-in-America 1 año hace
He made NOTHING.
👍️0
Invest-in-America Invest-in-America 1 año hace
SGTX: Because NO ONE on the entire iHub PLATFORM owned any of this Firm's shares yesterday --- nor for months!!! (Including glorious Mr. EZBucks chap.) And THAT is why, Bro.
👍️0
Invest-in-America Invest-in-America 1 año hace
Hey, Admiral Scotty, Mr. EZ did NOT have even one share of this Beast --- since he "alerted it" MONTHS ago. (However, just imagine the Peeps that DID own this yesterday; and, when one reads the Lily DEAL, they gots lots MORE CASH coming, no matter how that Investigation goes down!!!!)

PS: My 'CONGRATS' post to Mr. EZ was pure SARCASM!!! (I used to like that dude, but he's just jerk.)
👍️0
Invest-in-America Invest-in-America 1 año hace
SGTX: Well, King EZ --- since you must have grabbed a huge chunk of this at a paltry $0.66 months ago --- you surely must have dumped it all today for well over ONE-MILLION-DOLLARS profit!!! WOW, Dude!!! MONSTER CONGRATS to ya, Emperor EZ!!!!!



👍️0
TIMGZ TIMGZ 1 año hace
SGTX LIKE********THINKIN OF ***LXRX**WINT***GNPX****SLS***ORTX****PROBABLE ACQUISITION CANDIDATE. WHAT DO YOU THINK. THANKS
👍️0
TIMGZ TIMGZ 1 año hace
I KNOW YOU ALAWYS SHARE, KINDLY DO NOT LEAVE US ON THE SIDELINE. THANK YOU ALWAYS
👍️0
Roadtojourney Roadtojourney 1 año hace
This is huge news, why is no one talking about??
👍️0
BeamMeUpScotty BeamMeUpScotty 1 año hace
Why don’t you set up an alert service? There are plenty you can use that all you need to do is charge a nominal sum and then you can alert your entries with any other comments you want to add in real time.
👍️0
MiamiGent MiamiGent 1 año hace
SGTX "Nothing to see here"- already happened - but can marvel at :)

SIGILON THERAPEUTICS INC
$24.75 +20.82 (+529.77%)
As of Jun-29-2023

Sigilon Therapeutics Shares Are Shooting Higher Today - What's Going On
by BENZINGA

Sigilon Therapeutics Inc (NASDAQ:SGTX) shares are skyrocketing after Eli Lilly And Co (NYSE:LLY) agreed to acquire the company for a purchase price of $14.92 per share in cash (an aggregate of approximately $34.6 million).

Sigilon is also entitled to one non-tradeable contingent value right ("CVR") per share to receive up to an additional $111.64 per share in cash, for a total potential consideration of up to $126.56 per share in cash without interest (an aggregate of up to approximately $309.6 million excluding shares held by Lilly).

The transaction is not subject to any financing condition and is expected to close in the third quarter of 2023.

Since 2018, Lilly and Sigilon have worked together to develop encapsulated cell therapies, including SIG-002, for type 1 diabetes.

In the Q1 FY23 earnings release, Sigilon said its near-term focus is on development efforts for SIG-002, its product candidate for type 1 diabetes, which is being developed in collaboration with Eli Lilly.

Sigilon initiated IND-enabling activities for SIG-002 and anticipates initiating non-human primate (NHP) studies in 2H 2023. Additionally, the company expects an IND submission for SIG-002 in 2024.
👍️ 1
makinezmoney makinezmoney 1 año hace
$SGTX: Thanx dude.....................

Appreciate the KIND words.


Lots more to be made on the markets.......... got my eyes on more diamonds in the rough.

This isn't the only one


GO $SGTX
👍️0
TIMGZ TIMGZ 1 año hace
MAKINEZ, HOPE YOU BANK BIG! CONGRATS

DIAMOND IN A ROUGH COMES ONCE IN WHILE, THIS IS DEFINITELY ONE.
DANCING TO THE BANK AND GOOD FOR THE PUBLIC TOO.
NEW DRUG IS COMING TO THE MARKET PRETTY SOON
👍️0
makinezmoney makinezmoney 1 año hace
$SGTX: Gave it to you at $0.66 .... NOW $36 !!!!!!!!!!!!!


YEEEEEEEOWWwwwwwwwwwwwwwwwwwwwwwww...................... Y'all MAKIN EZ MONEY YET ???


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171441550


GO $SGTX
👍️0
tw0122 tw0122 1 año hace
Hope you made some $$$
👍️0
Awl416 Awl416 1 año hace
Lilly to Acquire Sigilon Therapeutics
👍️0
makinezmoney makinezmoney 2 años hace
$SGTX: Killer intraday mover........... from $0.74..........

And now $1.30 !!!!!!!!!!



YEEEEEEEEeeeowwwwwwwwwwwwwwwwwwwww........................ I'm running out of POSTS..


Where my loyal followers........... I've been giving you bangers lately,

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171438110


Hook me up with a ONE YEAR iHUB sub amigos.


GO $SGTX
👍️0
TrendTrade2016 TrendTrade2016 2 años hace
sgtx the next bio to soar...1.25 coming here
👍️0
makinezmoney makinezmoney 2 años hace
$SGTX: MarketCap only $11Milly.... Cash-on-HAND at $96Milly

I would say this can go up another $2share from here for sure.


Now at 0.66


GO $SGTX
👍️0
makinezmoney makinezmoney 2 años hace
$SGTX: Is it too late ?? now 0.70

Wish I saw this a lil earlier.


But nice pop there....................


https://ir.sigilon.com/static-files/94cc6b3f-5656-497a-a9be-0e8b4d1c1b36


GO $SGTX
👍️0
TrendTrade2016 TrendTrade2016 2 años hace
HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 2 años hace
SGTX ON THE MOVE
👍️0
crudeoil24 crudeoil24 4 años hace
Sigilon Therapeutics, Inc., a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced the pricing of its upsized initial public offering of 7,000,000 shares of its common stock at a public offering price of $18.00 per share. All of the shares are being offered by Sigilon. In addition, Sigilon has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. Sigilon’s common stock is expected to begin trading on the Nasdaq Global Market on December 4, 2020 under the symbol “SGTX.”
The gross proceeds of the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Sigilon, are expected to be $126.0 million excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on December 8, 2020, subject to the satisfaction of customary closing conditions.
👍️0
crudeoil24 crudeoil24 4 años hace
Sigilon Therapeutics Inc. is a clinical-stage biotechnology company seeking to develop functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients. The Company has developed its SLTx platform, which combines advanced cell engineering with advancements in biocompatible materials and enables its product candidates to produce a wide range of therapeutic molecules that may be missing or deficient, such as proteins, antibodies and enzymes. The Company’s lead product candidate is SIG-001, which is designed to prevent bleeding episodes in patients with moderate-severe to severe Hemophilia. The Company’s other product candidates includes SIG-009, SIG-003, SIG-005, SIG-007, SIG-018, SIG-002, SIG-014 and SIG-015.
👍️0
crudeoil24 crudeoil24 4 años hace
IPO > closing price > 34.78
👍️0

Su Consulta Reciente

Delayed Upgrade Clock